Skip to content
akaturk Academic measurement
2025 SJR Q3 OA

Journal detail

Drug Development and Registration

Country
Russian Federation · Eastern Europe
Type
journal
ISSN
  • 23052066
  • 26585049
Scopus 0,189 SJR
Scopus Q3 SJR Q
WoS JCR Q
WoS JIF
Scopus 10 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,189
  • Quartile Q3
  • H-Index 10
  • Cites/doc 0,47
  • Docs (3y) 333
  • Cites (3y) 172

Clarivate

Web of Science · JCR

No JCR match

Subject classification

Categories (SJR)

  • Drug Discovery Q4
  • Pharmaceutical Science Q3
  • Pharmacy Q3

Areas

  • Health Professions
  • Pharmacology, Toxicology and Pharmaceutics

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 0,189 10
2024 Q3 0,168 8
2023 Q3 0,187 8
2022 Q3 0,191 8
2021 Q3 0,156 8
2020 8
2019 8